1. Efficacy of alirocumab in heterozygous familial hypercholesterolemia or high cv risk populations: pooled analyses of eight phase 3 trials. Issue 1 (July 2015) Authors: Farnier, M.; Gaudet, D.; Valcheva, V.; Minini, P.; Miller, K.; Cariou, B. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗